KOL Knockout™ Cataract Edition: Heavy Hitters Discuss Using Next-Generation Technologies to Maximize Outcomes in Complex Cases

KOL Knockout Cataract Edition Heavy Hitters Discuss Using NextGeneration Technologies to Maximize Outcomes in Complex Cases
Details
Download PDF
  • Overview

    Content Source

    This continuing medical education (CME) activity captures content from three live-virtual symposia.

    Activity Description

    This supplement summarizes content from a series of three unique, live-virtual symposia hosted by Gary Wörtz, MD. The game show-style quiz competition with real-time audience voting featured cataract-focused case studies and discussions regarding patient care and surgical approaches among key opinion leaders/contestants.

    Target Audience

    This certified CME activity is designed for ophthalmologists.

    This activity is supported by an unrestricted educational grant from Alcon.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Identify the potential benefits and drawbacks of using femtosecond laser technology for cataract and refractive surgery
    • Discuss advances in adjunctive technologies for cataract surgery and how they can be used to improve refractive outcomes
    • Compare advanced intraocular lenses for cataract and refractive surgery patients to properly counsel patients and create personalized treatment plans based on patient expectations
    • Accreditation

      This educational activity is provided by Evolve Medical Education LLC (Evolve).

       

      Accreditation Statement
      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      The American Medical Association has an agreement of mutual recognition of CME credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu. Activities certified for AMA PRA Category 1 Credit™ that take place within a member country of the UEMS are not eligible for conversion to ECMEC®s under this agreement.

      Credit Designation Statement
      Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      Gary Wörtz, MD

      Gary Wörtz, MD

      Private practice

      Commonwealth Eye Surgery

      Lexington, KY


      Ashley Brissette, MD, MSc, FRCSC

      Ashley Brissette, MD, MSc, FRCSC

      Assistant Professor of Ophthalmology 

      Weill Cornell Medicine

      New York Presbyterian Hospital 

      New York, NY


      Preeya K. Gupta, MD

      Preeya K. Gupta, MD

      Managing Director

      Triangle Eye Consultants

      Raleigh, NC


      James C. Loden, MD

      James C. Loden, MD

      President 
      Loden Vision Centers 
      Nashville, TN


      Neda Shamie, MD

      Neda Shamie, MD

      Cataract, Refractive, and Corneal Surgeon

      Maloney-Shamie Vision Institute 

      Los Angeles, CA


      William B. Trattler, MD

      William B. Trattler, MD

      Cornea, Cataract, and Refractive Surgeon
      Center for Excellence in Eye Care
      Clinical Associate Professor
      Herbert Wertheim College of Medicine
      Florida International University
      Miami, FL



      Robert J. Weinstock, MD

      Robert J. Weinstock, MD

      Private Practice

      The Eye Institute of West Florida
      Largo, FL


      William F. Wiley, MD

      William F. Wiley, MD

      Medical Director

      Cleveland Eye Clinic

      Division of Midwest Vision Partners

      Cleveland, OH


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Gary Wörtz, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Johnson & Johnson, Lensar, and Ocuphire. Speaker's Bureau: Avellino. Stock/Shareholder: Arcuate Innovations and Omega Ophthalmics.

      Ashley Brissette, MD, MSc, FRCSC, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, Novartis, RxSight, Sun Pharmaceutical Industries, and TearLab. Grant/Research Support: Alcon.

      Preeya K. Gupta, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Aldeyra, Allergan, Azura, Carl Zeiss Meditec, Expert Opinion, HanAll Biopharma, Johnson & Johnson Vision, Kala Pharmaceuticals, New World Medical, Novartis, Ocular Science, Ocular Therapeutix, Orasis, Oyster Point, Sight Sciences, Spyglass, Sun Pharmaceutical Industries, Surface Ophthalmics, TearClear, TearLab, TissueTech, and Visionology.

      James C. Loden, MD, has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Johnson & Johnson Vision and Lensar. Grant/Research Support: Bausch + Lomb, Lenstec, and Johnson & Johnson Vision. Speaker's Bureau: Johnson & Johnson Vision. 

      Neda Shamie, MD, has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Avellino, Glaukos, Staar Surgical, and Tarsus.

      William B. Trattler, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Avellino, Azura Ophthalmics, Bausch + Lomb, Beaver-Visitec International, Bio-Tissue, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Speaker’s Bureau: Alcon, Allergan, Avellino, Bausch + Lomb, Beaver-Visitec International, Carl Zeiss Meditec, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Stock/Shareholder: ArcScan and Visionary Fund.

      Robert J. Weinstock, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Beyeonics, EyePoint Pharmaceuticals, Johnson & Johnson Vision, Lensar, and Visus. Speaker's Bureau: Johnson & Johnson Vision. Shareholder: Eyesafe, RPS, RxSight, TissueTech, uBeam, and Visus.

      William F. Wiley, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Imprimis, and RxSight.

      The Evolve staff, planners, reviewer, and writers have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, Cataract & Refractive Surgery Today Europe, MillennialEYE, or Alcon.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    1.00 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free